Giovanni Grazioso (G Grazioso)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Topics

Low Density Lipoprotein

Molecular Docking

Single Molecule

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Albani, Enrico Mario Alessandro Fassi, Roberta Manuela Moretti, Mariangela Garofalo, Marina Montagnani Marelli, Gabriella Roda, Jacopo Sgrignani, Andrea Cavalli, Giovanni Grazioso
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines. International journal of molecular sciences 25 (9) (2024)
Marco Albani, Enrico Mario Alessandro Fassi, Roberta Manuela Moretti, Mariangela Garofalo, Marina Montagnani Marelli, Gabriella Roda, Jacopo Sgrignani, Andrea Cavalli, Giovanni Grazioso
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines. International journal of molecular sciences 25 (9) (2024)
Maria Assunta Chiacchio, Laura Legnani, Enrico Mario Alessandro Fassi, Gabriella Roda, Giovanni Grazioso
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands. Molecules (Basel, Switzerland) 28 (6) (2023)
Alessandro Ratti, Enrico Mario Alessandro Fassi, Fabio Forlani, Matteo Mori, Federica Villa, Francesca Cappitelli, Jacopo Sgrignani, Gabriella Roda, Andrea Cavalli, Stefania Villa, Giovanni Grazioso
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid. Pharmaceutics 15 (6) (2023)
Alessandro Ratti, Enrico Mario Alessandro Fassi, Fabio Forlani, Maurizio Zangrossi, Matteo Mori, Francesca Cappitelli, Gabriella Roda, Stefania Villa, Federica Villa, Giovanni Grazioso
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA. Antioxidants (Basel, Switzerland) 12 (8) (2023)
Maria Assunta Chiacchio, Laura Legnani, Enrico Mario Alessandro Fassi, Gabriella Roda, Giovanni Grazioso
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands. Molecules (Basel, Switzerland) 28 (6) (2023)
Maria Assunta Chiacchio, Laura Legnani, Enrico Mario Alessandro Fassi, Gabriella Roda, Giovanni Grazioso
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands. Molecules (Basel, Switzerland) 28 (6) (2023)
Enrico Mario Alessandro Fassi, Marco Manenti, Andrea Citarella, Michele Dei Cas, Sara Casati, Nicola Micale, Tanja Schirmeister, Gabriella Roda, Alessandra Silvani, Giovanni Grazioso
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors. Molecules (Basel, Switzerland) 28 (5) (2023)
Carmen Lammi, Enrico Mario Alessandro Fassi, Marco Manenti, Marta Brambilla, Maria Conti, Jianqiang Li, Gabriella Roda, Marina Camera, Alessandra Silvani, Giovanni Grazioso
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity. Journal of medicinal chemistry (2023)
Alessandro Ratti, Enrico Mario Alessandro Fassi, Fabio Forlani, Matteo Mori, Federica Villa, Francesca Cappitelli, Jacopo Sgrignani, Gabriella Roda, Andrea Cavalli, Stefania Villa, Giovanni Grazioso
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid. Pharmaceutics 15 (6) (2023)
Enrico Mario Alessandro Fassi, Marco Manenti, Andrea Citarella, Michele Dei Cas, Sara Casati, Nicola Micale, Tanja Schirmeister, Gabriella Roda, Alessandra Silvani, Giovanni Grazioso
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors. Molecules (Basel, Switzerland) 28 (5) (2023)
Samuele Ciceri, Diego Colombo, Enrico Mario Alessandro Fassi, Patrizia Ferraboschi, Giovanni Grazioso, Paride Grisenti, Marco Nicola Iannone, Carlo Castellano, Fiorella Meneghetti
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study. Molecules (Basel, Switzerland) 28 (9) (2023)
Samuele Ciceri, Diego Colombo, Enrico Mario Alessandro Fassi, Patrizia Ferraboschi, Giovanni Grazioso, Paride Grisenti, Marco Nicola Iannone, Carlo Castellano, Fiorella Meneghetti
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study. Molecules (Basel, Switzerland) 28 (9) (2023)
Enrico Mario Alessandro Fassi, Marco Manenti, Andrea Citarella, Michele Dei Cas, Sara Casati, Nicola Micale, Tanja Schirmeister, Gabriella Roda, Alessandra Silvani, Giovanni Grazioso
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors. Molecules (Basel, Switzerland) 28 (5) (2023)
Carmen Lammi, Enrico Mario Alessandro Fassi, Jianqiang Li, Martina Bartolomei, Giulia Benigno, Gabriella Roda, Anna Arnoldi, Giovanni Grazioso
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity. Pharmaceutics 14 (3) (2022)
Enrico Mario Alessandro Fassi, Mariangela Garofalo, Jacopo Sgrignani, Michele Dei Cas, Matteo Mori, Gabriella Roda, Andrea Cavalli, Giovanni Grazioso
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity. International journal of molecular sciences 23 (9) (2022)
Jacopo Sgrignani, Valentina Cecchinato, Enrico Mario Alessandro Fassi, Gianluca D'Agostino, Maura Garofalo, Gabriela Danelon, Mattia Pedotti, Luca Simonelli, Luca Varani, Giovanni Grazioso, Mariagrazia Uguccioni, Andrea Cavalli
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction. Journal of medicinal chemistry 64 (18) (2021)
Yuchen Li, Gilda Aiello, Enrico Mario Alessandro Fassi, Giovanna Boschin, Martina Bartolomei, Carlotta Bollati, Gabriella Roda, Anna Arnoldi, Giovanni Grazioso, Carmen Lammi
Investigation of Chlorella pyrenoidosa Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides. Nutrients 13 (5) (2021)
Carmen Lammi, Gilda Aiello, Carlotta Bollati, Jianqiang Li, Martina Bartolomei, Giulia Ranaldi, Simonetta Ferruzza, Enrico Mario Alessandro Fassi, Giovanni Grazioso, Yula Sambuy, Anna Arnoldi
Trans-Epithelial Transport, Metabolism, and Biological Activity Assessment of the Multi-Target Lupin Peptide LILPKHSDAD (P5) and Its Metabolite LPKHSDAD (P5-Met). Nutrients 13 (3) (2021)
Jacopo Sgrignani, Enrico Mario Alessandro Fassi, Carmen Lammi, Gabriella Roda, Giovanni Grazioso
Exploring Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design. ChemMedChem 15 (16) (2020)
Benjamin J Tombling, Carmen Lammi, Nicole Lawrence, Edward K Gilding, Giovanni Grazioso, David J Craik, Conan K Wang
Bioactive Cyclization Optimizes the Affinity of a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Peptide Inhibitor. Journal of medicinal chemistry 64 (5) (2020)
Mariangela Garofalo, Giovanni Grazioso, Andrea Cavalli, Jacopo Sgrignani
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs. Molecules (Basel, Switzerland) 25 (7) (2020)
Carmen Lammi, Jacopo Sgrignani, Anna Arnoldi, Giordano Lesma, Claudia Spatti, Alessandra Silvani, Giovanni Grazioso
Computationally Driven Structure Optimization, Synthesis, and Biological Evaluation of Imidazole-Based Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibitors. Journal of medicinal chemistry 62 (13) (2019)
Carmen Lammi, Jacopo Sgrignani, Anna Arnoldi, Giovanni Grazioso
Biological Characterization of Computationally Designed Analogs of peptide TVFTSWEEYLDWV (Pep2-8) with Increased PCSK9 Antagonistic Activity. Scientific reports 9 (1) (2019)
Mattia Stucchi, Giovanni Grazioso, Carmen Lammi, Silvia Manara, Chiara Zanoni, Anna Arnoldi, Giordano Lesma, Alessandra Silvani
Disrupting the PCSK9/LDLR protein-protein interaction by an imidazole-based minimalist peptidomimetic. Organic & biomolecular chemistry 14 (41) (2018)
Giovanni Grazioso, Carlotta Bollati, Jacopo Sgrignani, Anna Arnoldi, Carmen Lammi
First Food-Derived Peptide Inhibitor of the Protein-Protein Interaction between Gain-of-Function PCSK9D374Y and the Low-Density Lipoprotein Receptor. Journal of agricultural and food chemistry 66 (40) (2018)
Stefania Villa, Laura Legnani, Diego Colombo, Arianna Gelain, Carmen Lammi, Daniele Bongiorno, Denise P Ilboudo, Kellen E McGee, Jürgen Bosch, Giovanni Grazioso
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors. Journal of computer-aided molecular design 32 (3) (2018)
Jacopo Sgrignani, Filomena De Luca, Hayarpi Torosyan, Jean-Denis Docquier, Da Duan, Beatrice Novati, Fabio Prati, Giorgio Colombo, Giovanni Grazioso
Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors. Journal of computer-aided molecular design 30 (10) (2016)
Laura Legnani, Diego Colombo, Assunta Venuti, Claudia Pastori, Lopalco Lucia, Lucio Toma, Matteo Mori, Giovanni Grazioso, Stefania Villa
Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity. MedChemComm 8 (2) (2016)